Passage Bio and Remix Therapeutics Announce Merger Agreement

Remix to go public in reverse merger with once high-flying Passage Bio

The transaction marks the latest turn in the fortunes of Passage Bio, one of the companies started by gene therapy pioneer Jim Wilson.

Passage Bio and Remix Therapeutics Announce Merger Agreement

Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies

Remix to take Nasdaq spot of Passage Bio in reverse merger for mRNA degrader

A nimble biotech working on small molecule mRNA degraders will take the Nasdaq listing of a once-promising gene therapy biotech co-founded by Jim Wilson. Remix Therapeutics plans to take over Passage Bio's ...